{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:01:58Z","timestamp":1785164518278,"version":"3.55.0"},"reference-count":26,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Radiological Research Trust","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"European Society of Gastrointestinal and Abdominal Radiology","award":["Research seed grant"],"award-info":[{"award-number":["Research seed grant"]}]},{"name":"Radiology Oncology Congresses","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,10]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>MR enterography (MRE) and intestinal ultrasound (IUS) are used to assess therapeutic response in Crohn\u2019s disease (CD) follow-up. There is, however, no clear guidance regarding which modality should be used for individual patients or if they are interchangeable. Therefore, clinical practice varies. We will compare the accuracy of MRE and IUS to classify treatment response in CD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>Multicentre, non-randomised, multiple arm, prospective cohort study of luminal CD patients aged 16 years or older being treated with steroids, immunomodulators, biologics\/biosimilars or small molecules with baseline MRE or IUS. The study will be based in three tertiary referral centres, UK (n=2) and Belgium (n=1), with a target sample size of 155 patients. Patients will undergo both MRE and IUS for response assessment within 20 months of baseline scanning, performed within 6 weeks of each other. One scan will be standard care, the other a research intervention. Interpreting radiologists will be masked to the alternative response assessment test. The primary outcome is the comparative accuracy of MRE and IUS for European Crohn\u2019s and Colitis Organisation-European Society of Gastrointestinal and Abdominal Radiology treatment response group categorisation compared with multidisciplinary consensus panel reference standard, using all available clinical information. Secondary outcomes include the influence of baseline scanning (MRE or IUS) on response characterisation accuracy, response accuracy of MRE and IUS disease activity scoring systems, management impact for each follow-up imaging modality and patient reported preferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This protocol has been approved by the National Health Service Research Ethics Committee and West of Scotland Research Ethics Committee 1 (24\/WS\/0121). Participant informed written consent will be obtained. Findings will be disseminated by peer-reviewed publications, conference presentations and patient and public involvement collaborators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT06800326\">NCT06800326<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-118654","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:35:35Z","timestamp":1785162935000},"page":"e118654","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic accuracy of magnetic resonance enterography and intestinal ultrasound for treatment response assessment in Crohn\u2019s disease (MANTRA): protocol for a multicentre, non-randomised, multiple-arm, prospective cohort comparison study"],"prefix":"10.1136","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct06800326","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06800326","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6290-5695","authenticated-orcid":false,"given":"Maira","family":"Hameed","sequence":"first","affiliation":[{"name":"University College London Centre for Medical Imaging, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busola","family":"Adebusoye","sequence":"additional","affiliation":[{"name":"University College London Centre for Medical Imaging, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0596-8200","authenticated-orcid":false,"given":"Sue","family":"Mallett","sequence":"additional","affiliation":[{"name":"University College London Centre for Medical Imaging, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Soteriou","sequence":"additional","affiliation":[{"name":"University College London Hospital Centre for Medical Imaging, University College London Hospital, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"De Kock","sequence":"additional","affiliation":[{"name":"Ghent University Hospital Radiology Department, Ghent, Flanders, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameed","family":"Rafiee","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Halligan","sequence":"additional","affiliation":[{"name":"University College London Centre for Medical Imaging, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6765-8806","authenticated-orcid":false,"given":"Stuart A","family":"Taylor","sequence":"additional","affiliation":[{"name":"University College London Centre for Medical Imaging, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"2026072707353012000_16.7.e118654.1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S2468-1253(18)30161-4","article-title":"Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn\u2019s disease (METRIC): a multicentre trial","volume":"3","author":"Taylor","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026072707353012000_16.7.e118654.2","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf106","article-title":"ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 1: initial diagnosis, monitoring of known inflammatory bowel disease, detection of complications","volume":"19","author":"Kucharzik","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026072707353012000_16.7.e118654.3","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf107","article-title":"ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2: IBD scores and general principles and technical aspects","volume":"19","author":"Yanai","year":"2025","journal-title":"J Crohns Colitis"},{"key":"2026072707353012000_16.7.e118654.4","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2021-102065"},{"key":"2026072707353012000_16.7.e118654.5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/17474124.2023.2274926","article-title":"Small bowel imaging in inflammatory bowel disease: updates for 2023","volume":"17","author":"Hameed","year":"2023","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2026072707353012000_16.7.e118654.6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/ecco-jcc\/jjab180","article-title":"ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease","volume":"16","author":"Kucharzik","year":"2022","journal-title":"J Crohns Colitis"},{"key":"2026072707353012000_16.7.e118654.7","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.241452","article-title":"How I Do It: Cross-sectional Imaging in Small-Bowel Crohn Disease and Ulcerative Colitis","volume":"314","author":"Hameed","year":"2025","journal-title":"Radiology"},{"key":"2026072707353012000_16.7.e118654.8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/RMR.0000000000000270","article-title":"MRE Evaluation of Intestinal Inflammation: Qualitative and Quantitative Assessment","volume":"30","author":"Grand","year":"2021","journal-title":"Top Magn Reson Imaging"},{"key":"2026072707353012000_16.7.e118654.9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326562"},{"key":"2026072707353012000_16.7.e118654.10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/bjr\/tqaf050","article-title":"A British Society of Gastrointestinal and Abdominal Radiology multi-centre audit of imaging investigations in inflammatory bowel disease","volume":"98","author":"Taylor","year":"2025","journal-title":"Br J Radiol"},{"key":"2026072707353012000_16.7.e118654.11","unstructured":"Inflammatory bowel disease | NIHR JLA.. Available: https:\/\/www.jla.nihr.ac.uk\/priority-setting-partnerships\/inflammatory-bowel-disease [Accessed 30 Oct 2024]."},{"key":"2026072707353012000_16.7.e118654.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.10.055"},{"key":"2026072707353012000_16.7.e118654.13","first-page":"1943","article-title":"Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn\u2019s disease","volume":"19","author":"Tielbeek","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"2026072707353012000_16.7.e118654.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.03.051"},{"key":"2026072707353012000_16.7.e118654.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-016-0139-7","article-title":"Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn\u2019s disease: correlation with SES-CD and clinical-biological markers","volume":"16","author":"Stoppino","year":"2016","journal-title":"BMC Med Imaging"},{"key":"2026072707353012000_16.7.e118654.16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/apt.16700","article-title":"Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn\u2019s disease","volume":"55","author":"Allocca","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"2026072707353012000_16.7.e118654.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.008"},{"key":"2026072707353012000_16.7.e118654.18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00330-013-3010-z","article-title":"Evaluation of Crohn\u2019s disease activity: initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin","volume":"24","author":"Makanyanga","year":"2014","journal-title":"Eur Radiol"},{"key":"2026072707353012000_16.7.e118654.19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/ecco-jcc\/jjaa216","article-title":"Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn\u2019s Disease","volume":"15","author":"Novak","year":"2021","journal-title":"Journal of Crohn\u2019s and Colitis"},{"key":"2026072707353012000_16.7.e118654.20","unstructured":"Recommendations | Crohn\u2019s disease: management | Guidance | NICE. 2019. Available: https:\/\/www.nice.org.uk\/guidance\/ng129\/chapter\/Recommendations#maintaining-remission-in-crohns-disease [Accessed 2 Nov 2024]."},{"key":"2026072707353012000_16.7.e118654.21","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2018180100"},{"key":"2026072707353012000_16.7.e118654.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(04)01878-4"},{"key":"2026072707353012000_16.7.e118654.23","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1016\/j.cgh.2022.01.055","article-title":"Responsiveness of Magnetic Resonance Enterography Indices for Evaluation of Luminal Disease Activity in Crohn\u2019s Disease","volume":"20","author":"Han\u017eel","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026072707353012000_16.7.e118654.24","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00330-015-4036-1","article-title":"Monitoring Crohn\u2019s disease during anti-TNF-\u03b1 therapy: validation of the magnetic resonance enterography global score (MEGS) against a combined clinical reference standard","volume":"26","author":"Prezzi","year":"2016","journal-title":"Eur Radiol"},{"key":"2026072707353012000_16.7.e118654.25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ajg.2017.464","article-title":"Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn\u2019s Disease","volume":"113","author":"Takenaka","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2026072707353012000_16.7.e118654.26","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1097\/MIB.0000000000000882","article-title":"Ultrasonographic Changes at 12 Weeks of Anti-TNF Drugs Predict 1-year Sonographic Response and Clinical Outcome in Crohn\u2019s Disease: A Multicenter Study","volume":"22","author":"Ripoll\u00e9s","year":"2016","journal-title":"Inflamm Bowel Dis"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-118654","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T14:35:39Z","timestamp":1785162939000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-118654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,27]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjopen-2026-118654"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-118654","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}